Pro Medicus signs $44M in health contracts

Health imaging company Pro Medicus has announced the signing of $44 million in separate contracts through…

Memphasys inks maiden South-East Asian commercialisation agreement

Memphasys has signed an exclusive agreement with TMSC Vietnam for the sale and distribution of its…

Memphasys receives order for 1000 Felix cartridges across MENA markets

Memphasys continues to expand the global market for its Felix system with new orders from the…

Noxopharm leaps on confirmation of cancer-fighting potential with new Sofra data

Noxopharm has obtained new data showing how the Sofra technology platform will be leveraged to fight…
Short sellers

Cracks start to show in 4DX Medical as short sellers bite; JP Morgan sells off

Cracks in the share price of 4D Medical (ASX:4DX) have started to show as the company faces record high

Island Pharmaceuticals makes key appointment ahead of US biodefence trials

Island Pharmaceuticals has made a key appointment ahead of US biodefence trials and dose optimisation studies.

Bioxyne expands LATAM medicinal cannabis footprint with Costa Rica agreement

Bioxyne has signed an agreement for the first international supply of medicinal cannabis flower into Costa…

Amplia Therapeutics and ANZGOG to undertake ovarian cancer study

Amplia Therapeutics and the ANZOG have entered into an agreement to conduct a new clinical study…

Noxopharm brings in specialist support to help progress its US regulatory strategy

Clinical-stage Australian biotech company Noxopharm (ASX:NOX) has engaged a global clinical research organisation to support it in the lead-up to a pre-investigational
The Market Online Video

FDA greenlights Syntara’s Amsulostat Phase 2b, setting up big 2026 catalysts

Syntara has had a positive outcome from its in person Type C meeting with the US…